• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高胆固醇在与年龄相关的COVID-19致死率中的作用。

The role of high cholesterol in age-related COVID19 lethality.

作者信息

Wang Hao, Yuan Zixuan, Pavel Mahmud Arif, Jablonski Sonia Mediouni, Jablonski Joseph, Hobson Robert, Valente Susana, Reddy Chakravarthy B, Hansen Scott B

机构信息

Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, 33458, USA.

Department of Neuroscience, The Scripps Research Institute, Jupiter, FL, 33458, USA.

出版信息

bioRxiv. 2021 Jun 28:2020.05.09.086249. doi: 10.1101/2020.05.09.086249.

DOI:10.1101/2020.05.09.086249
PMID:32511366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7263494/
Abstract

Coronavirus disease 2019 (COVID19) is a respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China in 2019. The disease is notably severe in elderly and those with underlying chronic conditions. A molecular mechanism that explains why the elderly are vulnerable and why children are resistant is largely unknown. Here we show loading cells with cholesterol from blood serum using the cholesterol transport protein apolipoprotein E (apoE) enhances the entry of pseudotyped SARS-CoV-2 and the infectivity of the virion. Super resolution imaging of the SARS-CoV-2 entry point with high cholesterol shows almost twice the total number of endocytic entry points. Cholesterol concomitantly traffics angiotensinogen converting enzyme (ACE2) to the endocytic entry site where SARS-CoV-2 presumably docks to efficiently exploit entry into the cell. Furthermore, in cells producing virus, cholesterol optimally positions furin for priming SARS-CoV-2, producing a more infectious virion with improved binding to the ACE2 receptor. In vivo, age and high fat diet induces cholesterol loading by up to 40% and trafficking of ACE2 to endocytic entry sites in lung tissue from mice. We propose a component of COVID19 severity based on tissue cholesterol level and the sensitivity of ACE2 and furin to cholesterol. Molecules that reduce cholesterol or disrupt ACE2 localization with viral entry points or furin localization in the producer cells, may reduce the severity of COVID19 in obese patients.

摘要

2019冠状病毒病(COVID-19)是一种由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的呼吸道感染,该病毒于2019年起源于中国武汉。这种疾病在老年人和患有基础慢性病的人群中尤为严重。一种解释为何老年人易感染而儿童具有抵抗力的分子机制在很大程度上尚不清楚。在此,我们展示了利用胆固醇转运蛋白载脂蛋白E(apoE)将血清中的胆固醇加载到细胞中,可增强假型SARS-CoV-2的进入及病毒粒子的感染性。对具有高胆固醇的SARS-CoV-2进入点进行超分辨率成像显示,内吞进入点的总数几乎增加了一倍。胆固醇同时将血管紧张素原转化酶(ACE2)转运至内吞进入位点,SARS-CoV-2可能在此处停靠,从而有效地利用该位点进入细胞。此外,在产生病毒的细胞中,胆固醇能使弗林蛋白酶最佳定位,从而启动SARS-CoV-2,产生一种与ACE2受体结合力增强且感染性更强的病毒粒子。在体内,年龄和高脂肪饮食会使胆固醇加载量增加高达40%,并使ACE2从小鼠肺组织转运至内吞进入位点。我们提出,基于组织胆固醇水平以及ACE2和弗林蛋白酶对胆固醇的敏感性,这是导致COVID-19严重程度的一个因素。降低胆固醇或破坏ACE2在病毒进入点的定位或破坏其在产生病毒的细胞中弗林蛋白酶定位的分子,可能会降低肥胖患者中COVID-19的严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/b2ba67ebc56c/nihpp-2020.05.09.086249v5-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/d0f373119a57/nihpp-2020.05.09.086249v5-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/0c54367248d3/nihpp-2020.05.09.086249v5-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/dee9f9f21131/nihpp-2020.05.09.086249v5-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/3ca41a9aac0e/nihpp-2020.05.09.086249v5-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/b2ba67ebc56c/nihpp-2020.05.09.086249v5-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/d0f373119a57/nihpp-2020.05.09.086249v5-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/0c54367248d3/nihpp-2020.05.09.086249v5-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/dee9f9f21131/nihpp-2020.05.09.086249v5-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/3ca41a9aac0e/nihpp-2020.05.09.086249v5-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf5/8259567/b2ba67ebc56c/nihpp-2020.05.09.086249v5-f0005.jpg

相似文献

1
The role of high cholesterol in age-related COVID19 lethality.高胆固醇在与年龄相关的COVID-19致死率中的作用。
bioRxiv. 2021 Jun 28:2020.05.09.086249. doi: 10.1101/2020.05.09.086249.
2
The role of high cholesterol in SARS-CoV-2 infectivity.高胆固醇在 SARS-CoV-2 感染性中的作用。
J Biol Chem. 2023 Jun;299(6):104763. doi: 10.1016/j.jbc.2023.104763. Epub 2023 Apr 28.
3
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.
4
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients.载脂蛋白 E(APOE)与血管紧张素转换酶 2(ACE2)相互作用,抑制 COVID-19 患者体内的 SARS-CoV-2 细胞进入和炎症反应。
Signal Transduct Target Ther. 2022 Aug 1;7(1):261. doi: 10.1038/s41392-022-01118-4.
5
Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.人胎盘滋养层细胞表达 SARS-CoV-2 进入因子 ACE2、TMPRSS2 和 Furin。
mSphere. 2021 Apr 14;6(2):e00250-21. doi: 10.1128/mSphere.00250-21.
6
Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.疱疹病毒 4 型(EBV)裂解复制诱导 ACE2 表达并增强 SARS-CoV-2 假型病毒进入上皮细胞。
J Virol. 2021 Jun 10;95(13):e0019221. doi: 10.1128/JVI.00192-21.
7
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.天然和重组 SARS-CoV-2 分离株通过更有效地结合硫酸乙酰肝素和减少 S1/S2 裂解而迅速进化为更高的感染力。
J Virol. 2021 Oct 13;95(21):e0135721. doi: 10.1128/JVI.01357-21. Epub 2021 Aug 18.
8
ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal-Oral Routes.口腔上皮细胞中的ACE2和弗林蛋白酶表达可能通过呼吸道和粪口途径促进新冠病毒感染。
Front Med (Lausanne). 2020 Dec 10;7:580796. doi: 10.3389/fmed.2020.580796. eCollection 2020.
9
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.针对弗林蛋白酶的可行替代策略可破坏 SARS-CoV-2 感染周期。
Microbiol Spectr. 2022 Feb 23;10(1):e0236421. doi: 10.1128/spectrum.02364-21. Epub 2022 Feb 9.
10
Rhesus angiotensin converting enzyme 2 supports entry of severe acute respiratory syndrome coronavirus in Chinese macaques.恒河猴血管紧张素转换酶2支持严重急性呼吸综合征冠状病毒进入中国猕猴体内。
Virology. 2008 Nov 10;381(1):89-97. doi: 10.1016/j.virol.2008.08.016. Epub 2008 Sep 17.

引用本文的文献

1
Evidence of mitochondria origin of SARS-CoV-2 double-membrane vesicles: a review.SARS-CoV-2 双层囊膜的线粒体起源证据:综述。
F1000Res. 2024 Jul 10;10:1009. doi: 10.12688/f1000research.73170.2. eCollection 2021.
2
An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity.一种 ACAT 抑制剂抑制 SARS-CoV-2 复制并增强抗病毒 T 细胞活性。
PLoS Pathog. 2023 May 3;19(5):e1011323. doi: 10.1371/journal.ppat.1011323. eCollection 2023 May.
3
Membrane Rafts: Portals for Viral Entry.膜筏:病毒进入的门户

本文引用的文献

1
Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol.星形胶质细胞衍生胆固醇对神经元中β-淀粉样蛋白生成的调节作用。
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2102191118.
2
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.SARS-CoV-2 病毒进入宿主细胞和病理性合胞体的形成都需要胆固醇。
Elife. 2021 Apr 23;10:e65962. doi: 10.7554/eLife.65962.
3
Are smokers protected against SARS-CoV-2 infection (COVID-19)? The origins of the myth.吸烟者是否免受 SARS-CoV-2 感染(COVID-19)?谣言的起源。
Front Microbiol. 2021 Feb 4;12:631274. doi: 10.3389/fmicb.2021.631274. eCollection 2021.
4
Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle.肥胖、糖尿病与 COVID-19:一种从东方蔓延而来的传染病,撞上了不健康的西方生活方式所带来的后果。
Front Endocrinol (Lausanne). 2020 Sep 17;11:582870. doi: 10.3389/fendo.2020.582870. eCollection 2020.
NPJ Prim Care Respir Med. 2021 Feb 26;31(1):10. doi: 10.1038/s41533-021-00223-1.
4
SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis.SARS-CoV-2 通过网格蛋白介导的内吞作用感染细胞。
J Biol Chem. 2021 Jan-Jun;296:100306. doi: 10.1016/j.jbc.2021.100306. Epub 2021 Jan 19.
5
Cholesterol-modifying drugs in COVID-19.用于治疗新冠病毒病的胆固醇调节药物。
Oxf Open Immunol. 2020;1(1):iqaa001. doi: 10.1093/oxfimm/iqaa001. Epub 2020 Jun 18.
6
Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle.肥胖、糖尿病与 COVID-19:一种从东方蔓延而来的传染病,撞上了不健康的西方生活方式所带来的后果。
Front Endocrinol (Lausanne). 2020 Sep 17;11:582870. doi: 10.3389/fendo.2020.582870. eCollection 2020.
7
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients.住院前使用他汀类药物与 COVID-19 住院患者严重程度和恢复的关系。
Am J Cardiol. 2020 Dec 1;136:149-155. doi: 10.1016/j.amjcard.2020.09.012. Epub 2020 Sep 16.
8
Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.胆固醇 25-羟化酶通过耗竭膜胆固醇来抑制 SARS-CoV-2 和其他冠状病毒。
EMBO J. 2020 Nov 2;39(21):e106057. doi: 10.15252/embj.2020106057. Epub 2020 Oct 5.
9
Influenza A viruses use multivalent sialic acid clusters for cell binding and receptor activation.甲型流感病毒利用多价唾液酸簇进行细胞结合和受体激活。
PLoS Pathog. 2020 Jul 8;16(7):e1008656. doi: 10.1371/journal.ppat.1008656. eCollection 2020 Jul.
10
Cholesterol in quarantine.胆固醇处于隔离状态。
Nat Immunol. 2020 Jul;21(7):716-717. doi: 10.1038/s41590-020-0712-7.